Open Access. Powered by Scholars. Published by Universities.®
Health and Medical Administration Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
Articles 1 - 2 of 2
Full-Text Articles in Health and Medical Administration
Improving Human Papillomavirus (Hpv) Vaccination Rates Through Age-Based Flagging, Savannah Jo Garcia, Karen Lasater
Improving Human Papillomavirus (Hpv) Vaccination Rates Through Age-Based Flagging, Savannah Jo Garcia, Karen Lasater
Graduate Publications and Other Selected Works - Doctor of Nursing Practice (DNP)
DNP SCHOLARLY PROJECT ABSTRACT
BACKGROUND: Over forty million Americans are currently infected with human papillomavirus (HPV). HPV can cause life threatening cancers of the cervix, vagina, vulva, penis, anus, and throat. Only half of U.S. adolescents have completed the HPV vaccine series.
LOCAL PROBLEM: The setting for this evidence-based improvement project is a rural family practice clinic in Texas. Texas has the largest group of teenagers not protected against HPV in the country. The project’s purpose is to investigate the effect of age-based flagging on adolescent vaccination rates in a rural community through evidence-based practice.
METHODS: Project …
Improving Human Papillomavirus Vaccination Rates In Adolescents: A Quality Improvement Project, Keylea Marenda Harrison, Allyson Neal, Katie Ingram-Willard
Improving Human Papillomavirus Vaccination Rates In Adolescents: A Quality Improvement Project, Keylea Marenda Harrison, Allyson Neal, Katie Ingram-Willard
Graduate Publications and Other Selected Works - Doctor of Nursing Practice (DNP)
Abstract
Objective: The purpose of this quality improvement (QI) project was to implement an evidence-based intervention to improve the HPV vaccine series completion rates in the pediatric primary care setting. The goal of the project was to increase HPV series completion rates in adolescents aged 11 to 12 by 10% within 3 months of implementation of the intervention.
Methods: A multicomponent intervention was implemented at a pediatric primary care office that included a chart review of 11- and 12-year-old adolescents who had received their first and second dose of the HPV vaccine from June 2019 to June 2020 and patients …